Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Quantitative nested reverse transcriptase PCR vs. real-time PCR for measuring AML1/ETO (MTG8) transcripts.

M Takenokuchi1, C Yasuda, K Takeuchi

  • 1Department of Clinical Laboratory, Kobe University Hospital, Kobe, Japan.

Clinical and Laboratory Haematology
|April 1, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Formation and evolution of carbonaceous asteroid Ryugu: Direct evidence from returned samples.

Science (New York, N.Y.)·2022
Same author

Pebbles and sand on asteroid (162173) Ryugu: In situ observation and particles returned to Earth.

Science (New York, N.Y.)·2022
Same author

Variations in color and reflectance on the surface of asteroid (101955) Bennu.

Science (New York, N.Y.)·2020
Same author

Sample collection from asteroid (162173) Ryugu by Hayabusa2: Implications for surface evolution.

Science (New York, N.Y.)·2020
Same author

An artificial impact on the asteroid (162173) Ryugu formed a crater in the gravity-dominated regime.

Science (New York, N.Y.)·2020
Same author

Journal of Artificial Organs 2019: the year in review : Journal of Artificial Organs Editorial Committee.

Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs·2020

A new quantitative nested reverse transcriptase polymerase chain reaction (QN-RT-PCR) method offers superior sensitivity for detecting the AML1/ETO fusion transcript. This advanced technique aids in predicting relapse and quantifying minimal residual disease (MRD) in acute myeloid leukemia patients.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biotechnology

Background:

  • Acute myeloid leukemia (AML) with t(8;21) translocation involves the AML1/ETO fusion transcript.
  • Accurate detection of minimal residual disease (MRD) is crucial for predicting relapse and guiding treatment.
  • Existing real-time PCR methods have limitations in sensitivity for MRD detection.

Purpose of the Study:

  • To develop and validate a highly sensitive quantitative nested reverse transcriptase polymerase chain reaction (QN-RT-PCR) method.
  • To compare the sensitivity of QN-RT-PCR with existing real-time PCR methods for detecting the AML1/ETO fusion transcript.
  • To assess the utility of QN-RT-PCR for predicting hematological relapse and quantifying MRD in AML patients.

Main Methods:

  • Development of a QN-RT-PCR assay using a plasmid cDNA standard containing the AML1/ETO fusion transcript.

Related Experiment Videos

  • Detection limits were determined for both plasmid standards and spiked cancer cells.
  • Comparison of QN-RT-PCR with real-time PCR in clinical samples from AML patients in remission.

    • Main Results:

    • The QN-RT-PCR method demonstrated a higher sensitivity, detecting the fusion transcript at 10(-17) m, compared to 10(-16) m for real-time PCR.
    • QN-RT-PCR detected the transcript 60 days before relapse in one patient, versus 10 days for real-time PCR.
    • Significant quantitative differences in MRD levels were observed between patients achieving remission via chemotherapy and bone marrow transplantation versus chemotherapy alone.

    Conclusions:

    • The developed QN-RT-PCR method is significantly more sensitive than conventional real-time PCR for detecting the AML1/ETO fusion transcript.
    • This enhanced sensitivity allows for earlier prediction of hematological relapse in AML patients.
    • QN-RT-PCR provides a valuable tool for precise quantitative assessment of MRD, differentiating treatment outcomes.